Consistent with the literature, we substantiated that liver transplantation is feasible in this patient population; indeed, postoperative HAART therapy can suppress the viral load, stabilize CD4 T-cell count, and lead to no significant increase in opportunistic infections [14–16]. The gene discussed is CD4; the disease is Opportunistic infection.